首页> 外文期刊>Eurosurveillance >Bacterial sexually transmitted infections in France: recent trends and patients’ characteristics in 2016
【24h】

Bacterial sexually transmitted infections in France: recent trends and patients’ characteristics in 2016

机译:法国的细菌性传播感染:2016年的近期趋势和患者特征

获取原文
获取外文期刊封面目录资料

摘要

Diagnoses of bacterial sexually transmitted infections (STI) have been increasing in France since their resurgence in the late 1990s. This article presents recent epidemiological trends until 2016 and the patients’ characteristics. STI surveillance relies on sentinel networks: a clinician-based network RésIST (clinical, biological and behavioural data for early syphilis and gonorrhoea), the lymphogranuloma venereum (LGV) network (clinical, biological and behavioural data for rectal LGV, and the laboratory networks Rénachla and Rénago (demographic and biological data for chlamydial infections and gonorrhoea, respectively). Here we describe trends between 2014 and 2016, using data from diagnostic centres which participated regularly during the study period. The number of early syphilis, gonorrhoea and LGV diagnoses increased between 2014 and 2016, particularly in men who have sex with men. An increase in syphilis and gonorrhoea cases was also observed in heterosexuals. Nevertheless, we observed a drop in 2016 for syphilis and chlamydial infections after two decades of increases. Under-reporting and shortage of benzathine penicillin in 2016 may explain this latest evolution. Regular screening of patients and partners, followed by prompt treatment, remains essential to interrupt STI transmission in a context where human immunodeficiency virus (HIV) prevention has expanded towards biomedical prophylaxis.
机译:自1990年代后期以来,细菌性传播感染(STI)的诊断在法国一直在增加。本文介绍了直到2016年的流行病学趋势以及​​患者的特征。 STI监测依靠前哨网络:基于临床医生的网络RésIST(早期梅毒和淋病的临床,生物学和行为数据),性病性淋巴肉芽肿(LGV)网络(直肠LGV的临床,生物学和行为数据)以及实验室网络Rénachla和Rénago(衣原体感染和淋病的人口统计学和生物学数据),这里我们使用研究期间定期参与的诊断中心的数据描述了2014年至2016年之间的趋势,早期梅毒,淋病和LGV诊断的次数在2014年和2016年,尤其是在与男性发生性关系的男性中,异性恋者的梅毒和淋病病例也有所增加,尽管如此,我们观察到梅毒和衣原体感染在经过了二十年的增长后在2016年有所下降。于2016年使用苄星青霉素的药物可能解释了这一最新进展。在人类免疫缺陷病毒(HIV)预防已扩展到生物医学预防的情况下,s和随后的迅速治疗仍然是中断STI传播的关键。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号